The National Agency for Science and Engineering Infrastructure (NASENI) has reaffirmed its determination to position Nigeria as a continental leader in healthcare manufacturing following the visit of a delegation of about 85 global health experts from Harvard University’s Science of Defeating Malaria Programme to its biotechnology factory in Abuja.
The visit provided an opportunity for the international experts to assess the agency’s growing investment in biotechnology, medical manufacturing, and scientific innovation aimed at strengthening Nigeria’s healthcare sector and reducing dependence on imported medical products.
Furthermore, members of the delegation reportedly expressed admiration for the facility’s capacity and technological advancement, describing it as a significant step toward expanding local healthcare manufacturing and promoting scientific excellence across Africa.
Strengthening Nigeria’s Healthcare Manufacturing Capacity
NASENI stated that developing indigenous manufacturing capabilities remains central to the Federal Government’s vision of achieving greater self-reliance in the production of healthcare equipment, medical devices, diagnostics, and other essential products.
The agency explained that increased local production will help reduce import dependence while improving access to affordable and quality healthcare products for millions of Nigerians.
In addition, expanding domestic manufacturing capacity is expected to strengthen the country’s health security by ensuring the availability of critical medical supplies during emergencies and disease outbreaks.
Innovation Driving National Development
The agency reiterated that science, technology, and engineering remain powerful drivers of economic transformation and industrial growth.
By investing in biotechnology research, advanced manufacturing, and innovation, NASENI aims to create an ecosystem that supports scientific discoveries while encouraging commercial production capable of meeting both domestic and international demand.
Moreover, technology-driven industrialisation is expected to stimulate investment, promote knowledge transfer, and enhance Nigeria’s competitiveness within the global healthcare industry.
International Collaboration Enhances Research
The visit by experts from Harvard University’s Science of Defeating Malaria Programme underscores the importance of international partnerships in advancing scientific research and healthcare innovation.
Such collaborations create opportunities for knowledge exchange, technical cooperation, and joint research initiatives that can accelerate solutions to major public health challenges affecting Africa and the wider global community.
Furthermore, partnerships between Nigerian institutions and leading international research organisations strengthen capacity building while encouraging innovation that addresses local healthcare needs.
Supporting Economic Diversification Through Biotechnology
NASENI believes that biotechnology and healthcare manufacturing offer enormous opportunities for economic diversification, employment generation, and industrial expansion.
The agency noted that investments in research laboratories, production facilities, and skilled human capital will support the emergence of a vibrant biotechnology sector capable of contributing significantly to national economic growth.
Consequently, stronger local manufacturing capacity will not only improve healthcare delivery but also create opportunities for exports and increased participation in regional and global value chains.
Building a Future of Scientific Excellence
The agency reaffirmed its commitment to expanding Nigeria’s technological capabilities through strategic investments in innovation, engineering, and biotechnology infrastructure. It maintained that sustained collaboration with academic institutions, international research organisations, and private sector stakeholders will further accelerate the country’s healthcare manufacturing ambitions.
As Nigeria continues to pursue industrialisation and technological advancement, NASENI’s biotechnology initiatives represent an important step toward building a resilient healthcare manufacturing sector that supports economic growth, promotes scientific excellence, and positions the country as a leading centre for healthcare innovation and production across the African continent.
